PTC Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Liabilities
PTC Therapeutics, Inc. (PTCT) reported Increase (Decrease) in Other Noncurrent Liabilities of $1.93 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2019-03-01
- PTC Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2016-12-31 was -$1.48M.
- PTC Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2016-09-30 was $681.00K.
- PTC Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2016-06-30 was $24.00K.
- PTC Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2016-03-31 was -$23.00K.
- PTC Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2018 was $1.93M, a 163.57% increase from fiscal 2017.
- PTC Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2017 was $733.00K.
- PTC Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2016 was -$799.00K.
- PTC Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2015 was -$92.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 12 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | $1.93M 10-K · filed 2019-03-01 | ||||||
| 2017-12-31 | $733.00K 10-K · filed 2019-03-01 | ||||||
| 2016-12-31 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$800.00K derived: sum of 2 quarters · filed 2019-03-01 | -$776.00K derived: sum of 3 quarters · filed 2019-03-01 | -$799.00K 10-K · filed 2019-03-01 | |||
| 2016-09-30 | $681.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $705.00K derived: sum of 2 quarters · filed 2016-11-03 | $682.00K 10-Q · filed 2016-11-03 | $659.00K derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.00K 10-Q · filed 2016-08-04 | -$22.00K derived: sum of 3 quarters · filed 2018-03-06 | -$45.00K derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-03-31 | -$23.00K 10-Q · filed 2016-05-05 | -$46.00K derived: sum of 2 quarters · filed 2018-03-06 | -$69.00K derived: sum of 3 quarters · filed 2018-03-06 | -$92.00K derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2015-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | -$46.00K derived: sum of 2 quarters · filed 2018-03-06 | -$69.00K derived: sum of 3 quarters · filed 2018-03-06 | -$92.00K 10-K · filed 2018-03-06 | |||
| 2015-09-30 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$46.00K derived: sum of 2 quarters · filed 2016-11-03 | -$69.00K 10-Q · filed 2016-11-03 | -$81.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$46.00K 10-Q · filed 2016-08-04 | -$58.00K derived: sum of 3 quarters · filed 2017-03-16 | -$80.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | -$23.00K 10-Q · filed 2016-05-05 | -$35.00K derived: sum of 2 quarters · filed 2017-03-16 | -$57.00K derived: sum of 3 quarters · filed 2017-03-16 | -$80.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$34.00K derived: sum of 2 quarters · filed 2017-03-16 | -$57.00K derived: sum of 3 quarters · filed 2017-03-16 | -$80.00K 10-K · filed 2017-03-16 | |||
| 2014-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$45.00K derived: sum of 2 quarters · filed 2015-11-09 | -$68.00K 10-Q · filed 2015-11-09 | -$91.00K derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | -$46.00K 10-Q · filed 2015-07-31 | -$69.00K derived: sum of 3 quarters · filed 2016-02-29 | -$334.00K derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$23.00K 10-Q · filed 2015-05-05 | -$46.00K derived: sum of 2 quarters · filed 2016-02-29 | -$311.00K derived: sum of 3 quarters · filed 2016-02-29 | -$309.00K derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$288.00K derived: sum of 2 quarters · filed 2016-02-29 | -$286.00K derived: sum of 3 quarters · filed 2016-02-29 | -$285.00K 10-K · filed 2016-02-29 | -$285.24K 10-K · filed 2014-03-06 | ||
| 2013-09-30 | -$265.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$263.00K derived: sum of 2 quarters · filed 2014-11-06 | -$262.00K 10-Q · filed 2014-11-06 | -$262.43K 10-Q · filed 2013-11-14 | -$90.57K derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $3.00K 10-Q · filed 2014-08-07 | $3.03K 10-Q · filed 2013-08-13 | $174.43K derived: sum of 3 quarters · filed 2015-03-02 | $151.62K derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-03-31 | $1.00K 10-Q · filed 2014-05-06 | $172.43K derived: sum of 2 quarters · filed 2015-03-02 | $149.62K derived: sum of 3 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $171.43K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $148.62K derived: sum of 2 quarters · filed 2015-03-02 | $103.00K 10-K · filed 2015-03-02 | $102.76K 10-K · filed 2014-03-06 | |||
| 2012-09-30 | -$22.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$68.43K 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | -$45.62K 10-Q · filed 2013-08-13 | ||||||
| 2011-12-31 | -$67.15K 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |